Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach

Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach

Bibliographic Details
Main Authors: Shuaibing Liu, Ziteng Wang, Xin Tian, Weimin Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Pharmacology
Subjects:
vicagrel
clopidogrel
CYP2C19
carboxylesterase
physiologically based pharmacokinetic/pharmacodynamic model
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.668861/full
id doaj-c94103ee1e8b4de187bb6e07cccd31e7
record_format Article
spelling doaj-c94103ee1e8b4de187bb6e07cccd31e72021-04-16T12:49:22ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-04-011210.3389/fphar.2021.668861668861Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling ApproachShuaibing Liu0Ziteng Wang1Xin Tian2Weimin Cai3Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of ClinicalPharmacy, School of Pharmacy, Fudan University, Shanghai, ChinaDepartment of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of ClinicalPharmacy, School of Pharmacy, Fudan University, Shanghai, Chinahttps://www.frontiersin.org/articles/10.3389/fphar.2021.668861/fullvicagrelclopidogrelCYP2C19carboxylesterasephysiologically based pharmacokinetic/pharmacodynamic model
collection DOAJ
language English
format Article
sources DOAJ
author Shuaibing Liu
Ziteng Wang
Xin Tian
Weimin Cai
spellingShingle Shuaibing Liu
Ziteng Wang
Xin Tian
Weimin Cai
Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
Frontiers in Pharmacology
vicagrel
clopidogrel
CYP2C19
carboxylesterase
physiologically based pharmacokinetic/pharmacodynamic model
author_facet Shuaibing Liu
Ziteng Wang
Xin Tian
Weimin Cai
author_sort Shuaibing Liu
title Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_short Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_full Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_fullStr Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_full_unstemmed Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_sort corrigendum: predicting the effects of cyp2c19 and carboxylesterases on vicagrel, a novel p2y12 antagonist, by physiologically based pharmacokinetic/pharmacodynamic modeling approach
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2021-04-01
topic vicagrel
clopidogrel
CYP2C19
carboxylesterase
physiologically based pharmacokinetic/pharmacodynamic model
url https://www.frontiersin.org/articles/10.3389/fphar.2021.668861/full
work_keys_str_mv AT shuaibingliu corrigendumpredictingtheeffectsofcyp2c19andcarboxylesterasesonvicagrelanovelp2y12antagonistbyphysiologicallybasedpharmacokineticpharmacodynamicmodelingapproach
AT zitengwang corrigendumpredictingtheeffectsofcyp2c19andcarboxylesterasesonvicagrelanovelp2y12antagonistbyphysiologicallybasedpharmacokineticpharmacodynamicmodelingapproach
AT xintian corrigendumpredictingtheeffectsofcyp2c19andcarboxylesterasesonvicagrelanovelp2y12antagonistbyphysiologicallybasedpharmacokineticpharmacodynamicmodelingapproach
AT weimincai corrigendumpredictingtheeffectsofcyp2c19andcarboxylesterasesonvicagrelanovelp2y12antagonistbyphysiologicallybasedpharmacokineticpharmacodynamicmodelingapproach
_version_ 1721525398062235648

Similar Items